# CYMBALTA
> **NDA022516** · New Drug Application · Sponsor: LILLY · Approved 2010-11-04
## Drug
- **FDA Application Number:** NDA022516
- **Application type:** New Drug Application
- **Brand name:** CYMBALTA
- **Generic name:** Duloxetine Hydrochloride
- **Active ingredients:** DULOXETINE HYDROCHLORIDE
- **Dosage form:** CAPSULE, DELAYED REL PELLETS
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LILLY
- **First approval:** 2010-11-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022516)
---
*MORVS · CC0 1.0*